Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,172 | 93,641 | 385,721 | 39,133 | -224,282 |
| Depreciation Amortization | 25 | 43,184 | 45,843 | 42,651 | 39,517 |
| Income taxes - deferred | N/A | 37,894 | -291,880 | 275 | 113 |
| Accounts payable and accrued liabilities | 363 | N/A | N/A | N/A | N/A |
| Other Working Capital | 521 | 246,580 | -321,937 | -54,157 | -5,686 |
| Loans | N/A | 318,545 | -308,844 | -44,176 | -31,231 |
| Other Operating Activity | -58 | -327,055 | 364,598 | 100,346 | 294,812 |
| Operating Cash Flow | $-4,321 | $412,789 | $-126,499 | $84,072 | $73,243 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -19,365 | -9,853 | -15,881 | -3,034 |
| Net Acquisitions | N/A | -150,120 | 121,098 | N/A | N/A |
| Purchase Of Investment | N/A | -322,965 | -291,583 | -770,876 | -2,358,667 |
| Sale Of Investment | N/A | 399,332 | 1,513,571 | 1,122,203 | 1,670,953 |
| Net Loans | N/A | -709,294 | -361,096 | -194,280 | 1,450,121 |
| Other Investing Activity | 0 | 64,264 | 82,791 | 237,235 | 152,612 |
| Investing Cash Flow | $-58 | $-738,148 | $1,054,928 | $378,401 | $911,985 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -5,188 | -18,896 | 23,251 | -16,634 |
| Debt Issued | N/A | 1,875,000 | 545,000 | 0 | 538,050 |
| Debt Repayment | N/A | -1,360,158 | -345,210 | -1,519 | -1,478,995 |
| Common Stock Issued | N/A | 868 | 661 | 0 | 683,334 |
| Dividend Paid | N/A | -59,195 | -49,743 | N/A | N/A |
| Other Financing Activity | 0 | -50,000 | -485,342 | 0 | 0 |
| Financing Cash Flow | $N/A | $564,169 | $-1,099,150 | $-403,457 | $-1,138,428 |
| Beginning Cash Position | 6,037 | 299,878 | 470,599 | 411,583 | 564,783 |
| End Cash Position | 1,658 | 538,688 | 299,878 | 470,599 | 411,583 |
| Net Cash Flow | $-4,379 | $238,810 | $-170,721 | $59,016 | $-153,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,321 | 412,789 | -126,499 | 84,072 | 73,243 |
| Capital Expenditure | -58 | N/A | N/A | N/A | -3,034 |
| Free Cash Flow | -4,379 | 412,789 | -126,499 | 84,072 | 70,209 |